Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 8116 to 8130 of 8216 results

  1. Tislelizumab with platinum-based chemotherapy and etoposide for untreated extensive-stage small-cell lung cancer [ID6158]

    Awaiting development [GID-TA11094] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  2. Tislelizumab for treating advanced non-small-cell lung cancer after platinum-based chemotherapy [ID6161]

    Awaiting development [GID-TA11099] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  3. Tislelizumab in combination for untreated advanced non-small-cell lung cancer [ID6162]

    Awaiting development [GID-TA11101] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  4. Insulin icodec for treating type 1 and type 2 diabetes ID6175

    In development [GID-TA11104] Expected publication date: TBC

    Technology appraisal guidance
    In development

  5. Adrenal insufficiency: identification and management

    In development [GID-NG10237] Expected publication date: 28 August 2024

    NICE guideline
    In development

  6. Children and young people with disabilities and severe complex needs: integrated health and social care support

    Awaiting development [GID-QS10146] Expected publication date: TBC

    Quality standard
    Awaiting development

  7. Adults with lifelong or very severe hearing or visual impairment: health, well-being and social care

    Awaiting development [GID-QS10144] Expected publication date: TBC

    Quality standard
    Awaiting development

  8. Pelvic floor dysfunction

    Awaiting development [GID-QS10129] Expected publication date: TBC

    Quality standard
    Awaiting development

  9. High linear energy transfer radiation for carbon ion beam therapy

    Register an interest in this interventional procedure   ...

    Interventional procedures guidance
    Topic selection

  10. Differential Target Multiplexed Spinal Cord Stimulation (MT742)

      Status ...

    Medical technologies guidance
    Topic selection

  11. Tirzepatide for managing overweight and obesity [ID6179]

    In development [GID-TA11156] Expected publication date: 30 October 2024

    Technology appraisal guidance
    In development

  12. Iptacopan for treating paroxysmal nocturnal haemoglobinuria [ID6176]

    In development [GID-TA11132] Expected publication date: 26 June 2024

    Technology appraisal guidance
    In development

  13. Degarelix before or with radiotherapy for treating high-risk localised and locally advanced hormone-dependent prostate cancer [ID6419]

    In development [GID-TA11443] Expected publication date: TBC

    Technology appraisal guidance
    In development

  14. Teclistamab for treating relapsed or refractory multiple myeloma after 3 treatments (Review of TA869) [ID6333]

    In development [GID-TA11418] Expected publication date: 14 August 2024

    Technology appraisal guidance
    In development

  15. Linzagolix for treating moderate to severe symptoms of uterine fibroids [ID6190]

    In development [GID-TA11131] Expected publication date: TBC

    Technology appraisal guidance
    In development